Urine drug screening in adolescents

Pediatric Clinics of North America

Volumn 49, Issue 2, 2002, Pages 317-327

  Casavant, Marcel J ^a,b  

^a Central Ohio Poison Center   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD HEALTH CARE; DRUG SCREENING; HUMAN; LABORATORY TEST; MEDICAL ETHICS; QUANTITATIVE DIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; URINALYSIS;

ADOLESCENT; HUMANS; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 0036230746     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(01)00006-2     Document Type: Review

References (31)

1. Pediatrician’s role in the diagnosis and treatment of substance abuse
2. ACMT Position statement concerning urine analysis for cocaine metabolites
3. Utility of comprehensive toxicologic screens in children
4. Efficacy of two commercial products for altering urine drug test results
5. American Association of Pediatrics: Testing for drugs of abuse in children and adolescents
6. Scientific issues in drug testing
7. Blood boosting and sport
8. Therapeutic drug levels and toxicology screens
9. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: Use for detecting maternal and neonatal drug exposures
10. The old “ounce of prevention
11. Validity of self-report of drug use among STD patients, ER patients, and arrestees
12. Passive smoking in children: Racial differences in systemic exposure to cotinine by hair and urine analysis
13. Substance use measures among women in early pregnancy
14. Decision making in laboratory test studies
15. Laboratory testing in emergency toxicology
16. Drug screening versus history in detection of substance use in ED psychiatric patients
17. Bayes’ theorem: A review
18. Testing for drugs of abuse: Controversies and techniques
19. Urine testing in the detection of drugs of abuse
20. Mandatory guidelines for federal workplace drug testing programs
21. Mandatory guidelines for federal workplace drug testing programs
22. Mandatory guidelines for federal workplace drug testing programs
23. Drug use and abuse in sport
24. Detection of illicit opioid and cocaine use in methadone maintenance treatment
25. Difficult diagnoses in toxicology: Poisons not detected by the comprehensive drug screen
26. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: An external quality assessment scheme using clinically realistic urine samples
27. Review of biological indicators of illicit drug use, practical considerations and clinical usefulness
28. Doping among adolescent athletes